🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12496+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12496 recruiting trials

Phase 3RecruitingNCT05136976

Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders

👨‍⚕️ Anne-Laure KAMINSKY, MD, CHU de Saint-Etienne📍 15 sites📅 Started Jun 2023View details ↗
RecruitingNCT06083363

Longitudinal Recovery Trajectories After an Acute Respiratory Distress Syndrome, a New Understanding

👨‍⚕️ Jessica González Gutiérrez, MD, PhD, Institut de Recerca Biomèdica de Lleida📍 3 sites📅 Started Jun 2023View details ↗
Phase 1RecruitingNCT05625594

Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma

👨‍⚕️ Tanya Siddiqi, City of Hope Medical Center📍 1 site📅 Started Jun 2023View details ↗
Phase 2RecruitingNCT05821088

Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma

👨‍⚕️ David A Bond, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Jun 2023View details ↗
RecruitingNCT05686278

Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty

👨‍⚕️ Christophe HULET, MD, PhD, University Hospital, Caen📍 4 sites📅 Started Jun 2023View details ↗
Phase 4RecruitingNCT05962840

Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)

👨‍⚕️ Jing Li, MD, Peking Unione Mdecial College Hospital📍 1 site📅 Started Jun 2023View details ↗
Phase 2RecruitingNCT05661643

The Efficacy and Safety of Temozolomide in SDH-deficient GIST

🏥 Asan Medical Center📍 1 site📅 Started Jun 2023View details ↗
Phase 1, PHASE2RecruitingNCT05806099

A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL

🏥 Beijing Mabworks Biotech Co., Ltd.📍 1 site📅 Started Jun 2023View details ↗
RecruitingNCT05787821

Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)

👨‍⚕️ Hillary Overholser, Zimmer Biomet📍 16 sites📅 Started Jun 2023View details ↗
NARecruitingNCT05810402

Liver Cancer and Immunotherapy in the Liquid Biopsy Era

👨‍⚕️ Catherine Alix-Panabières, Ph.D., University Hospital, Montpellier📍 1 site📅 Started Jun 2023View details ↗
EARLY_Phase 1RecruitingNCT05937841

Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia

👨‍⚕️ Anna Reid-Stanhewicz, PhD, University of Iowa📍 1 site📅 Started Jun 2023View details ↗
RecruitingNCT06016946

Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study

👨‍⚕️ David Lynch, MD, Children's Hospital of Philadelphia📍 34 sites📅 Started Jun 2023View details ↗
RecruitingNCT05934149

Lupus Landmark Study: A Prospective Registry and Biorepository

👨‍⚕️ Sam Lim, MD, MPH, Emory University📍 21 sites📅 Started Jun 2023View details ↗
NARecruitingNCT05766774

FEED-Cystic Fibrosis (FEED-CF)

👨‍⚕️ Jessica A Alvarez, PhD, RD, Emory University📍 1 site📅 Started Jun 2023View details ↗
Phase 1, PHASE2RecruitingNCT06052436

Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)

👨‍⚕️ Rafael Correa-Rocha, PhD, Hospital General Universitario Gregorio Marañon📍 1 site📅 Started Jun 2023View details ↗
NARecruitingNCT05858034

Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older

👨‍⚕️ Caryn G Morse, MD, MPH, Wake Forest University Health Sciences📍 1 site📅 Started Jun 2023View details ↗
Phase 1RecruitingNCT05389423

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

👨‍⚕️ Ramya M Ramaswami, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Jun 2023View details ↗
Phase 2RecruitingNCT05708352

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

👨‍⚕️ Jethro Hu, MD, Cedars-Sinai Medical Center📍 5 sites📅 Started Jun 2023View details ↗
NARecruitingNCT05776472

A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

👨‍⚕️ Study Physician +46 08-697-20 00, medical.info@sobi.com, Swedish Orphan Biovitrum📍 20 sites📅 Started Jun 2023View details ↗
Phase 1RecruitingNCT05698524

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

👨‍⚕️ Nicole A Shonka, MD, University of Nebraska📍 1 site📅 Started Jun 2023View details ↗
← PreviousPage 395 of 625Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →